New aspects of probiotics - A novel approach in the management of food allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 9, 1999, Pages 909-915

  Kirjavainen, Pirkka V ^a   Apostolou, E ^a   Salminen, S J ^a   Isolauri, E ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Food allergy; Immunomodulation; Normal microflora; Probiotics; Safety

Indexed keywords

PROBIOTIC AGENT;

CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; FOOD ALLERGY; HUMAN; IMMUNE SYSTEM; IMMUNOPOTENTIATION; INFLAMMATION; INTESTINE FLORA; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; PRIORITY JOURNAL; REVIEW; SAFETY;

ANIMALS; BACTERIAL PHYSIOLOGY; FOOD HYPERSENSITIVITY; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; INTESTINES; MOUTH; PROBIOTICS;

EID: 0032878396     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00103.x     Document Type: Review

References (59)

1. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-185.
2. Ouwehand AC, Kirjavainen PV, Shortt C, Salminen S. Probiotics: mechanisms and established effects. Int Dairy J 1999;9:43-52.
3. Salminen S, Bouley C, Boutron-Ruault M-C, et al. Functional food science and gastrointestinal physiology and function. Hr J Nutr 1998;80:S147-S171.
4. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993;105:1643-1650.
5. Sanderson IR, Walker WA. Uptake and transport of macromolecules by the intestine: Possible role in clinical disorders (an update). Gastroenterology 1993;104:622-639.
6. Fargeas MJ, Theodorou V, More J, Wal JM, Fioramonti J, Bueno L. Boosted systemic immune and local responsiveness after intestinal inflammation in orally sensitized guinea pigs. Gastroenterology 1995;109:53-62.
7. van de Merwe JP, Stegeman JH, Hazenberg MP. The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease?. Antonie Van Leeuwenhoek 1983;49:119-124.
8. Gaboriau-Routhiau V, Moreau MC. Gut flora allows recovery of oral tolerance to ovalbumin in mice after transient breakdown mediated by cholera toxin or Escherichia coli heat-labile enterotoxin. Pediatr Res 1996;39:625-629.
9. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-1745.
10. Bauer H, Paronetto F, Burns WA, Einheber A. The enhancing effect of the microbial flora on macrophage function and the immune response. A study in germfree mice. J Exp Med 1966;123:1013-1024.
11. MacDonald TT, Carter PB. Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells. J Immunol 1979;112:2624-2629.
12. Pulverer G, Ko HL, Roszkowski W, Beuth J, Yassin A, Jeljaszewicz J. Digestive tract microflora liberates low molecular weight peptides with immunotriggering activity. Int J Med Microbiol 1990;272:318-327.
13. Klinman DM, Yi A-K, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad Sci U S A 1996;93:2879-2883.
14. Carter LL, Zhang X, Dubey C, Rogers P, Tsui L, Swain SL. Regulation of T cell subsets from naive to memory. J Immunother 1998;21:181-187.
15. Ledru E, Lecocur H, Garcia S, Debord T, Gougeon ML. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunother 1998;160:3194-3206.
16. Weiner HL, Gonnella PA, Slavin A, Maron R. Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines. Res Immunol 1997;148:528-533.
17. Dahlgren UIH, Wold AE, Hanson LA, Midtvedt T. Expression of a dietary protein in E. coli renders it strongly antigenic to gut lymphoid tissue. Immunology 1991;73:394-397.
18. Shaternikov VA, Kuvaeva ID, Ladodo KS, Orlova NG, Veselova OL. General and local humoral immunity and intestinal microflora in children with skin manifestations of food allergy. Vopr Pitan 1982;Sep-Oct:51-56.
19. Loskutova IE. Effectiveness of using Maliutka and Malysh adapted propionic-acidophilus mixtures in the combined treatment of congenital hypotrophy. Vopr Pitan 1985;May-Jun:17-20.
20. Trapp CL, Chang CC, Halpern GM, Keen CL, Gerschwin ME. The influence of chronic yoghurt consumption on population of young and elderly adults. Int J Immunother 1993;9:53-64.
21. Wheeler JG, Bogle ML, Sherna SJ, et al. Impact of dietary yoghurt on immune function. Am J Med Sci 1997;313:120-123.
22. 4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand J Immunol 1996;43:687-689.
23. Sütas Y, Soppi E, Korhonen H, et al. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J Allergy Clin Immunol 1996;98;216-224.
24. Madara JL. The chameleon within: improving antigen delivery. Science 1997;277:910-911.
25. Kankaanpää P, Sütas Y, Arvilommi H, Salminen S, Isolauri E. Comparison of antiproliferative effects of probiotic cell extracts and glucocorticoids. Gastroentezol Int 1998;11:S139.
26. Isolauri E, Pelto L, Nuutila J, Majamaa H, Lilius E-M, Salminen S. Altered expression of IgG and complement receptors indicates a significant role of phagocytes in atopic dermatitis. J Allergy Clin Immunol 1997;99:707-713.
27. Rangavajhyala N, Shahani KM, Sridevi G, Srikumaran S. Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1α and turnout necrosis factor-α by murine macrophages. Nutr Cancer 1997;28:130-134.
28. Perdigón G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holdago AA. Effect of perorally administered Lactobacilli on macrophage activation in mice. Infect Immun 1986;53:404-410.
29. Perdigón G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holdago AA. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus. J Dairy Sci 1987;70:919-926.
30. Perdigón G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holdago A. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 1988;63:17-23.
31. Perez-Chaia A, Nader de Macias ME, Oliver G. Propionihacteria in the gut: effect on some metabolic activities of the host. Lait 1995;75:435-445.
32. Schiffrin EJ, Rochat F, Link-Amster H, Acschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-492.
33. Perdigón G, Alvarez S, Pesce de Ruiz Holdago A. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J Dairy Res 1991;58:485-496.
34. Pelto L, Isolauri E, Lilius E-M, Nuutila J, Salminen S. Probiotic bacteria downregulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy 1998;28:1474-1479.
35. Lingnau K, Hoehn P, Kerdine S, et al. IL-4 in combination with TGF-β favours an alternative pathway of Th1 development independent of IL-12. J Immunol 998;161:4709-4718.
36. + T cells isolated from different mouse strains. J Immunol 1995;155:3788.
37. Moreau MC, Ducluzeau R, Guy-Grand D, Muller MC. Increase in the population of duodenal IgA plasmocytes in axenic mice monoassociated with different living or dead bacterial strains of intestinal origin. Infect Immun 1978;21:532-539.
38. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992;33:141-144.
39. Yasui H, Nagaoka N, Mike A, Hayakawa K, Ohwaki M. Detection of Bifidobacterium strains that induce large quantities of IgA. Microb Ecol Health Dis 1992;5:155-162.
40. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995;20:333-338.
41. Takahashi T, Nakagawa E, Nara T, Yajima T, Kuwata T. Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens. Biosci Biotechnol Biochem 1998;62:10-15.
42. Mestecky J, Russell MW, Elson CO. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 1999;44:2-5.
43. de Simone C, Ciardi A, Grassi A, et al. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 1992;14;331-340.
44. Miettinen M, Vuopio-Varkkila J, Varkkila K. Production of human tumour necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria, Infect Immun 1996;64:5403-5404.
45. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 1998;81:48-53.
46. Shida K, Makino K, Morishita A, et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 1998;115:278-287.
47. Hernandez-Pando R, Rook GA. The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology. 1994;82:591-595.
48. Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst Pasteur 1994;92:45-67.
49. Aguirre M, Collins MD. Lactic acid bacteria and human clinical infection. J Appl Bacteriol 1993;75:95-107.
50. Salminen S, von Wright A, Morelli L, et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998;44:93-106.
51. Wagner RD, Warner T, Roberts L, Farmer J, Balish E. Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect Immun 1997;65:3345-3351.
52. Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 1998;36:325-326.
53. Oakey HJ, Harty DWS, Knox KW. Enzyme production by lactobacilli and the potential link with infective endocarditis. J Appl Bacteriol 1995;78:142-148.
54. Harty DWS, Oakey HJ, Patrikakis M, Hume BBH, Knox KW. Pathogenic potential of lactobacilli. Int J Food Microbiol 1994;24:179-189.
55. Kirjavainen PV, Tuomola EM, Crittenden RG, et al. In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli. Infect Immun 1999;67:2653-2655.
56. Kirjavainen PV, Ouwchand AC, Isolauri E, Salminen SJ. The ability of probiotic bacteria to hind to human intestinal mucus. FEMS Microb Lett 1998;167:185-189.
57. Tuomola E, Salminen S. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 1998;41:45-51.
58. Jonas DA, Antignac E, Antoine J-M, et al. The safety assessment of novel foods. Guidelines prepared by ILSI Europe novel foods task force. Food Chem Toxicol 1996;34:931-940.
59. Kernéis S, Bogdanova A, Krachenbuhl J-P, Pringault E. Conversion by Peyer's patch lymphocytes of human erythrocytes into M cells that transport bacteria. Science 1997;277:949-952.